EC Number   |
Inhibitors |
Structure  |
|---|
   3.4.22.1 | more |
not inhibitory: Z-FY(tert-butyl)-CHN(2) |
 |
| 3.4.22.1 | more |
analysis of further dipeptidyl nitriles as selective inhibitors |
|
| 3.4.22.1 | more |
no inhibition with N-chloroacetyl-Gly-Gly-OH |
|
| 3.4.22.1 | more |
no inhibition with pepstatin A at 0.005 and 0.1 mM |
|
| 3.4.22.1 | more |
no inhibition of CmCatB1 by PMSF, leupeptin, pepstatin A, ethanol and DMSO |
|
| 3.4.22.1 | more |
ruthenium(II)-arene compounds behave as powerful inhibitors |
|
| 3.4.22.1 | more |
inhibitory activities of N-cyano-tetrahydro-pyridazine derivatives, docking studies, overview |
|
| 3.4.22.1 | more |
inhibitor screening and docking studies to cathepsin B, overview. Predicted bioactivities of inhibitor candidates and molecular mechanics |
|
| 3.4.22.1 | more |
the inhibition of cathepsin B causes accumulation of 26-kDa pro-TNF-containing vesicles |
|
| 3.4.22.1 | more |
inhibition of cathepsin B by antitumor ruthenium(II)-arene compounds, mechanisms of binding/inhibition, overview |
|
